Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (156)
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
1998 • 5,063 citations
Epidemiology of Parkinson's disease
2006 • 3,818 citations
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
2000 • 3,559 citations
Mitochondrial Membrane Permeabilization in Cell Death
2007 • 3,375 citations
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
2004 • 3,278 citations
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
2003 • 2,691 citations
Oxidative stress in Parkinson's disease
2003 • 2,001 citations
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
2000 • 1,975 citations
The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
1999 • 1,872 citations
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
1989 • 1,717 citations
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
2000 • 1,628 citations
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
2006 • 1,489 citations
Association between Early-Onset Parkinson's Disease and Mutations in theParkinGene
2000 • 1,398 citations
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
2002 • 1,178 citations
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
2005 • 1,172 citations
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
2003 • 1,156 citations
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization
2004 • 1,091 citations
Abnormalities of the electron transport chain in idiopathic parkinson's disease
1989 • 1,067 citations
An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin
2001 • 1,048 citations
Parkin functions as an E2-dependent ubiquitin– protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1
2000 • 975 citations
Effects of Coenzyme Q10 in Early Parkinson Disease
2002 • 965 citations
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
2004 • 959 citations
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
2003 • 884 citations
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
2007 • 864 citations
Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons
2006 • 861 citations
DJ‐1 has a role in antioxidative stress to prevent cell death
2004 • 828 citations
Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
2002 • 760 citations
A common LRRK2 mutation in idiopathic Parkinson's disease
2005 • 758 citations
S -Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function
2004 • 750 citations
DJ-1, a Novel Oncogene Which Transforms Mouse NIH3T3 Cells in Cooperation withras
1997 • 736 citations
Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
1989 • 735 citations
Parkinson's Disease Brain Mitochondrial Complex I Has Oxidatively Damaged Subunits and Is Functionally Impaired and Misassembled
2006 • 703 citations
α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
2000 • 694 citations
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress
2005 • 676 citations
Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease
1990 • 676 citations
Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death
2006 • 648 citations
Origin and functional consequences of the complex I defect in Parkinson's disease
1996 • 629 citations
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
2005 • 600 citations
AnIn VitroModel of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage
2002 • 575 citations
DJ-1 Is a Redox-Dependent Molecular Chaperone That Inhibits α-Synuclein Aggregate Formation
2004 • 572 citations
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
2002 • 569 citations
Altered Proteasomal Function in Sporadic Parkinson's Disease
2002 • 565 citations
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons
2007 • 561 citations
Mitochondrial disease
2006 • 557 citations
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
2005 • 554 citations
Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease
2003 • 543 citations
Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations
2005 • 535 citations
Parkinsonism, premature menopause, and mitochondrial DNA polymerase γ mutations: clinical and molecular genetic study
2004 • 535 citations
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
2004 • 531 citations
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
2005 • 520 citations
Nigrostriatal Dopaminergic Deficits and Hypokinesia Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1
2005 • 518 citations
PINK1 mutations are associated with sporadic early‐onset parkinsonism
2004 • 480 citations
Lewy bodies and parkinsonism in families with parkin mutations
2001 • 479 citations
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1
2007 • 467 citations
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
2005 • 464 citations
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease
2004 • 454 citations
Mitochondrial DNA Variants Observed in Alzheimer Disease and Parkinson Disease Patients
1993 • 449 citations
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
2005 • 448 citations
Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism
2005 • 442 citations
Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease
1995 • 430 citations
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease
2006 • 426 citations
Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboons
1996 • 422 citations
Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis
2005 • 418 citations
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration
2005 • 412 citations
Genetic and environmental factors in the cause of Parkinson's disease
2003 • 383 citations
Neuroprotective Role of the Reaper-Related Serine Protease HtrA2/Omi Revealed by Targeted Deletion in Mice
2004 • 383 citations
Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity
1999 • 372 citations
Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway
2001 • 365 citations
Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability
2005 • 363 citations
Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition
2003 • 358 citations
Platelet mitochondria function in Parkinson's disease
1992 • 350 citations
Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence
1990 • 345 citations
BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
1992 • 341 citations
Early-onset parkinsonism associated with PINK1 mutations
2005 • 335 citations
PINK1 protein in normal human brain and Parkinson's disease
2006 • 328 citations
Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome system
2006 • 325 citations
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
2003 • 323 citations
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease
1998 • 313 citations
DJ-1 Positively Regulates the Androgen Receptor by Impairing the Binding of PIASxα to the Receptor
2001 • 312 citations
Mitochondrial involvement in Parkinson’s disease, Huntington’s disease, hereditary spastic paraplegia and Friedreich’s ataxia
1999 • 309 citations
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage
2005 • 304 citations
How much phenotypic variation can be attributed to parkin genotype?
2003 • 291 citations
Novel pharmacological targets for the treatment of Parkinson's disease
2006 • 290 citations
Immunohistochemical and subcellular localization of parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients
1999 • 274 citations
Parkin enhances mitochondrial biogenesis in proliferating cells
2006 • 261 citations
Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease
2003 • 259 citations
The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis
2005 • 246 citations
Lewy body Parkinson's disease in a large pedigree with 77Parkin mutation carriers
2005 • 242 citations
Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe
2003 • 242 citations
Complex I, Iron, and ferritin in Parkinson's disease substantia nigra
1994 • 239 citations
Early‐onset familial parkinsonism due to POLG mutations
2006 • 232 citations
Novel PINK1 mutations in early-onset parkinsonism
2005 • 226 citations
Biochemical and pathological characterization of Lrrk2
2006 • 223 citations
Identification of Mitochondrial DNA Polymorphisms That Alter Mitochondrial Matrix pH and Intracellular Calcium Dynamics
2006 • 219 citations
Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease
2006 • 215 citations
Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations
2003 • 212 citations
An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in theparkin gene
2000 • 209 citations
A randomized clinical trial of coenzyme Q 10 and GPI-1485 in early Parkinson disease
2007 • 208 citations
Clinical and subclinical dopaminergic dysfunction in PARK6‐linked parkinsonism: An 18F‐dopa PET study
2002 • 201 citations
Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease
1994 • 201 citations
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
2005 • 201 citations
Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity
2000 • 198 citations
Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease
2003 • 196 citations
Randomized, Double-blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q10 in Parkinson Disease
2007 • 195 citations
Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial
2006 • 194 citations
Analysis of the PINK1 Gene in a Large Cohort of Cases With Parkinson Disease
2004 • 193 citations
Clinical features ofLRRK2-associated Parkinson's disease in central Norway
2005 • 186 citations
Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD
2005 • 179 citations
TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial
2006 • 176 citations
A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy
2000 • 173 citations
A heterozygous effect for PINK1 mutations in Parkinson's disease?
2006 • 163 citations
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease
2005 • 162 citations
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress
2006 • 161 citations
Inhibitory effects of pesticides on proteasome activity: Implication in Parkinson's disease
2006 • 153 citations
LRRK2 mutations in Parkinson disease
2005 • 152 citations
Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline
2006 • 149 citations
A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations
2005 • 149 citations
Point mutations of mitochondrial genome in Parkinson's disease
1995 • 147 citations
Treatment Options in the Modern Management of Parkinson Disease
2007 • 139 citations
Clinical Spectrum of Homozygous and Heterozygous PINK1 Mutations in a Large German Family With Parkinson Disease
2006 • 136 citations
Parkin is associated with cellular vesicles
2001 • 132 citations
Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism
2004 • 129 citations
Pesticide Exposure Exacerbates α-Synucleinopathy in an A53T Transgenic Mouse Model
2007 • 128 citations
Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease
1991 • 123 citations
An out-of-frame cytochromeb gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production
2000 • 118 citations
Clinical and Genetic Heterogeneity in Progressive External Ophthalmoplegia Due to Mutations in Polymerase γ
2003 • 115 citations
Parkin Phosphorylation and Modulation of Its E3 Ubiquitin Ligase Activity
2004 • 114 citations
Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins
1998 • 112 citations
mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish
2003 • 111 citations
Mitochondrial ND5 mutations in idiopathic Parkinson’s disease
2004 • 111 citations
Mitochondrial DNA analysis in Parkinson's disease
1990 • 109 citations
PINK1 mutations in sporadic early‐onset Parkinson's disease
2006 • 99 citations
The dardarin G2019S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases
2005 • 97 citations
Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondrial function.
1993 • 95 citations
A Novel Polymerase γ Mutation in a Family With Ophthalmoplegia, Neuropathy, and Parkinsonism
2004 • 94 citations
Parkin expression in the adult mouse brain
2000 • 92 citations
Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases
1986 • 92 citations
Oxidative stress in Parkinson's disease
1995 • 87 citations
Mutation of the Linker Region of the Polymerase γ-1 (POLG1Gene Associated With Progressive External Ophthalmoplegia and Parkinsonism
2007 • 82 citations
Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle
1995 • 79 citations
Sequence Analysis of the Entire Mitochondrial Genome in Parkinson's Disease
2002 • 78 citations
Smoking and mitochondrial function: a model for environmental toxins
1993 • 74 citations
BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential
2003 • 66 citations
A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease
1994 • 62 citations
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na+/K+ ATPase
2006 • 51 citations
Novel mitochondrial DNA mutations in Parkinson's disease
2002 • 46 citations
The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism
2004 • 43 citations
Analysis of the trinucleotide CAG repeat from the DNA polymerase γ gene (POLG) in patients with Parkinson's disease
2004 • 42 citations
Genetic association study of PINK1 coding polymorphisms in Parkinson's disease
2004 • 32 citations
Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis
2007 • 31 citations
G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage
2004 • 30 citations
The Importance of LRRK2 Mutations in Parkinson Disease
2006 • 30 citations
Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease
2007 • 28 citations
Parkinson disease: analysis of mitochondrial DNA in monozygotic twins.
2000 • 22 citations
Absence of the Mitochondrial A7237T Mutation in Parkinson′s Disease
1995 • 20 citations
Parkinson disease: analysis of mitochondrial DNA in monozygotic twins
2000 • 17 citations